Home > Press > Bruker Introduces HyperQuant™, a Unique Bench-Top NMR Reader to Quantify Hyperpolarization
Bruker Introduces HyperQuant(TM), a Unique Bench-Top NMR Reader to Quantify Hyperpolarization (Photo: Business Wire) |
Abstract:
At the 2008 World Molecular Imaging Congress (for details, see www.wmicmeeting.org), Bruker BioSpin introduces HyperQuant™, a bench-top NMR reader for precisely quantifying both the magnetic hyperpolarization as well as the thermal polarization of a sample. The HyperQuant applies time-domain nuclear magnetic resonance (TD-NMR) spectroscopy, a technology similar to magnetic resonance imaging (MRI).
Magnetic hyperpolarization promises to be a useful technique with potential to boost contrast in MRI and sensitivity in solid-state NMR. Hyperpolarization provides a means to increase the nuclear magnetic polarization by orders of magnitude compared to the thermal Boltzmann polarization. Today, hyperpolarization can be achieved by various mechanisms, including DNP (dynamic nuclear polarization) and parahydrogen-induced polarization (PHIP). Typically, carbon-13 labeled samples are utilized because of their preferential NMR properties.
The key applications requirement for Bruker BioSpin's new HyperQuant is that the polarization enhancement factor needs to be determined very precisely. Therefore, it is crucial to quantify both the hyperpolarization and the thermal polarization on the very same sample. The proprietary HyperQuant utilizes a unique permanent magnet combined with an innovative probe design (patents applied for) and novel NMR pulse sequences to enable the quantification of the thermal polarization of 13C-labeled samples using volumes as low as 1 ml. In this manner, hyperpolarization enhancement factors can be obtained directly and with confidence on the sample of interest, without having to go via a separate calibration reference.
The new HyperQuant offers a complete easy-to-use turnkey solution for any researcher developing new MRI or NMR applications for hyperpolarization.
####
About Bruker BioSpin
Bruker BioSpin is a subsidiary of Bruker Corporation
For more information, please click here
Contacts:
Bruker BioSpin GmbH
Dr. Dieter Schmalbein
+49-721-5161-0
Managing Director
Copyright © Business Wire 2008
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||